Table 2 Distribution of CCHD related neonatal mortality rates and infant mortality rates by CCHD types, Türkiye, 2018–2021 (n = 4083)
CCHD type | CCHD related infant mortality n (%)& | CCHD related NMR (1/10,000) | CCHD related IMR (1/10,000) |
|---|---|---|---|
Group 1 diseases | 2417 (59.2) | 3.0 | 5.2 |
Hypoplastic left heart syndrome | 1012 (24.8) | 1.5 | 2.2 |
Tetralogy of Fallot | 461 (11.3) | 0.4 | 1.0 |
Transposition of great arteries | 422 (10.3) | 0.4 | 0.9 |
Total anomalous pulmonary venous return | 191 (4.7) | 0.2 | 0.4 |
Pulmonary atresia with intact ventricular septum | 149 (3.6) | 0.2 | 0.3 |
Truncus arteriosus | 125 (3.1) | 0.1 | 0.3 |
Tricuspid atresia | 57 (1.4) | 0.06 | 0.1 |
Group 2 diseases | 1650 (40.4) | 1.5 | 3.6 |
Atrioventricular septal defect | 637 (15.6) | 0.3 | 1.4 |
Aortic arch anomalies* | 603 (14.8) | 0.7 | 1.3 |
Single ventricle physiology diseases** | 272 (6.7) | 0.3 | 0.6 |
Ebstein anomaly | 73 (1.8) | 0.1 | 0.2 |
Pulmonary valve stenosis | 65 (1.6) | 0.05 | 0.1 |
Ungrouped | 16 (0.4) | 0.02 | 0.03 |
Total | 4083(100.0) | 4.6 | 8.8 |